Who is the new President at Neumora?

Neumora named Henry Gosebruch President, announced July 18, 2023.

Which similar companies made leadership changes around the same time?

Rarebase (July 13, 2023), Elevation Oncology (July 13, 2023), Brainstorm Cell Therapeutics (July 12, 2023) and Bicara Therapeutics (July 24, 2023) also announced leadership changes within 45 days of Neumora.

Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer

PUBLIC · NMRAJul 18, 2023

Position

President

Company

Neumora

Henry Gosebruch

henry.gosebruch@neumoratx.com

WatertownBiotechnologyHealth CareTherapeuticsBiotechnology Research

Description

Neumora Therapeutics, Inc. , a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the appointment of Henry Gosebruch as president and chief executive officer and a member of the Company’s board. Co-founder Paul L

Quick answer

Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer (July 18, 2023). Neumora is based in Watertown, Massachusetts, United States.

Who is the new President at Neumora?: Neumora named Henry Gosebruch President, announced July 18, 2023.
What did Neumora announce on July 18, 2023?: Neumora Therapeutics, Inc. , a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the appointment of Henry Gosebruch as president and chief executive officer and a member of the Company’s board.
What does Neumora do?: Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people.
Where is Neumora based?: Neumora is based in Watertown, Massachusetts, United States.
Which similar companies made leadership changes around the same time?: Rarebase (July 13, 2023), Elevation Oncology (July 13, 2023), Brainstorm Cell Therapeutics (July 12, 2023) and Bicara Therapeutics (July 24, 2023) also announced leadership changes within 45 days of Neumora.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology Research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Rarebase Announces Promotion of Chris Moxham to President (July 13, 2023)
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer (July 13, 2023)
BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer (July 12, 2023)
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer (July 24, 2023)
Pheon Therapeutics Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer (July 25, 2023)
Acadia Pharmaceuticals Appoints Kevin Oliver Chief Business Officer (July 25, 2023)

Who to call at Neumora, and when

A new leader at Neumora brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day Neumora raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Neumora, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neumora. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neumora

Location

260 Arsenal Place, Suite 1

Watertown, Massachusetts, United States

About

Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people. However, treatments for many of the most prevalent brain disorders have been dominated by a single class of drugs, such as serotonin targeting antidepressants for MDD, leaving patients with a high degree of unmet medical need given the lack of diverse treatment options and mechanisms of action. We are taking a fundamentally different approach to the way treatments for brain diseases are developed. Our pipeline is comprised of programs pursuing therapeutically relevant targets implicated in Central Nervous System (CNS) diseases, each targeting a novel mechanism of action with best-in-class pharmacology. Our work is supported by our Precision Toolbox, which integrates a suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora is relentless in its commitment to discovering, developing and commercializing novel therapies for the 1.5 billion people living with brain diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neumora changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

Henry

Likely contact at this company

••••••••@••••••••

See Henry's verified email →

Create an account to reveal verified emails

Predictive Intelligence

Strategic

ML-powered predictions for Neumora's next move

Learn about Strategic plan

Neumora changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a recruiter uses this Or see plans and pricing →

5 screens from a live account. No signup.